transcranial direct current stimulation on neurological diseases

Efficacy and safety of transcranial direct current stimulation on neurological diseases

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs042210161

Enrollment

Registered

2022-03-17

Start date

2022-05-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple screlosis and neuromyelitis optica, parkinson's disease (including parkinson syndrome)

Interventions

Subjects are randomly divided into 2 groups: an intervention group (actual stimulation at the beginning) and sham group (sham stimulation at the beginning and stimulated by Transcranial direct current

tDCS, neurological disease

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Neurological diseases

Exclusion criteria

Exclusion criteria: Cases who have medical devices containing magnetic parts or electronic circuits in the bodies.

Design outcomes

Primary

Measure	Time frame
Expanded Disability Status Scale (EDSS), The MDS-sponsored Revision of the Unified Parkinson's Disease Rating Scale(MDS-UPDRS), Brief Repeatable Battery of Neuropsychological tests in multiple sclerosis(BRB-N), Visual analog scale(VAS), Numeric rating scale (NRS)	—

Secondary

Measure	Time frame
Biochemical Examination of blood, Magnetic Resonance Imaging(Brain)	—

Contacts

Public ContactRyoko Shibuya

Toyama University Hospital

ryosan@med.u-toyama.ac.jp+81-76-434-7309

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026